<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: gene mutation</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Women with BRCA mutations can take hormone-replacement therapy safely after ovary removal</title>
   	 <description>Women with the BRCA1 or BRCA2 gene mutations, which are linked to a very high risk of breast and ovarian cancer, can safely take hormone-replacement therapy (HRT) to mitigate menopausal symptoms after surgical removal of their ovaries, according to new research from the Perelman School of Medicine at the University of Pennsylvania which will be presented Monday, June 6 during the American Society for Clinical Oncology's annual meeting (Abstract #1501). Results of the prospective study indicated that women with BRCA mutations who had their ovaries removed and took short-term HRT had a decrease in the risk of developing breast cancer.</description>
	  <link>http://medicalxpress.com/news/2011-06-women-brca-mutations-hormone-replacement-therapy.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 01 Jun 2011 15:03:00 EST</pubDate>
	 <guid isPermaLink="false">news226159355</guid>
	 
</item>
<item>
     <title>DNA repair system affects colon cancer recurrence and survival</title>
   	 <description>Colorectal cancer patients with defects in mismatch repair--one of the body's systems for repairing DNA damage--have lower recurrence rates and better survival rates than patients without such defects, according to a study published online May 19th in the Journal of the National Cancer Institute.</description>
	  <link>http://medicalxpress.com/news/2011-05-dna-affects-colon-cancer-recurrence.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 19 May 2011 16:23:38 EST</pubDate>
	 <guid isPermaLink="false">news225040984</guid>
	 
</item>
<item>
     <title>Sickle cell anemia drug safe and effective for infants and toddlers, adds treatment option</title>
   	 <description>New research shows a drug commonly used to treat sickle cell anemia in adults reduces bouts of acute pain and a pneumonia-like illness, cuts hospitalization time and eases other symptoms of the disease in young patients. Results of the randomized, double-blind trial mark a dramatic advance in treatment of children with the inherited blood disorder.</description>
	  <link>http://medicalxpress.com/news/2011-05-sickle-cell-anemia-drug-safe.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 12 May 2011 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news224428066</guid>
	 
</item>


</channel>
</rss>
